Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. / Fitzsimmons, D.; Johnson, C. D.; George, S. et al.
In: European Journal of Cancer, Vol. 35, No. 6, 06.1999, p. 939-941.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Fitzsimmons, D, Johnson, CD, George, S, Payne, S, Andrén Sandberg, A, Bassi, C, Beger, HG, Birk, D, Büchler, MW, Dervenis, C, Fernandez Cruz, L, Friess, H, Grahm, AL, Jeekel, J, Laugier, R, Meyer, D, Singer, MW, Tihanyi, T & EORTC Study Group on Quality of Life, T 1999, 'Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer.', European Journal of Cancer, vol. 35, no. 6, pp. 939-941. https://doi.org/10.1016/S0959-8049(99)00047-7

APA

Fitzsimmons, D., Johnson, C. D., George, S., Payne, S., Andrén Sandberg, A., Bassi, C., Beger, H. G., Birk, D., Büchler, M. W., Dervenis, C., Fernandez Cruz, L., Friess, H., Grahm, A. L., Jeekel, J., Laugier, R., Meyer, D., Singer, M. W., Tihanyi, T., & EORTC Study Group on Quality of Life, T. (1999). Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. European Journal of Cancer, 35(6), 939-941. https://doi.org/10.1016/S0959-8049(99)00047-7

Vancouver

Fitzsimmons D, Johnson CD, George S, Payne S, Andrén Sandberg A, Bassi C et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. European Journal of Cancer. 1999 Jun;35(6):939-941. doi: 10.1016/S0959-8049(99)00047-7

Author

Fitzsimmons, D. ; Johnson, C. D. ; George, S. et al. / Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. In: European Journal of Cancer. 1999 ; Vol. 35, No. 6. pp. 939-941.

Bibtex

@article{3a56281589734862abedb48aa0bd1a23,

title = "Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer.",

abstract = "There is overwhelming consensus that quality of life assessment is urgently required in pancreatic cancer, yet little research has been conducted. We report on the development of a disease specific questionnaire module to supplement the EORTC core cancer module, the QLQ-C30 in patients with pancreatic cancer, using EORTC quality of life study group guidelines for module development. Relevant QoL issues were generated from literature searches and interviews with health professionals and patients with pancreatic cancer. Issues were constructed into items and provisionally translated. The provisional module was pretested in patients in 8 European centres. The resulting module the QLQ-PAN26 includes 26 items related to disease symptoms, treatment side-effects and emotional issues specific to pancreatic cancer. This should ensure that the module will be sensitive to assess the small but important disease and treatment related QoL changes in pancreatic cancer. The use of the QLQ-C30 and QLQ-PAN26 will provide a comprehensive system of QoL assessment in international trials of pancreatic cancer.",

keywords = "pancreatic neoplasm, quality of life, EORTC QLQ-C30, questionnaire",

author = "D. Fitzsimmons and Johnson, {C. D.} and S. George and Sheila Payne and {Andr{\'e}n Sandberg}, A. and C. Bassi and Beger, {H. G.} and D. Birk and B{\"u}chler, {M. W.} and C. Dervenis and {Fernandez Cruz}, L. and H. Friess and Grahm, {A. L.} and J. Jeekel and R. Laugier and D. Meyer and Singer, {M. W.} and T. Tihanyi and {EORTC Study Group on Quality of Life}, The",

year = "1999",

month = jun,

doi = "10.1016/S0959-8049(99)00047-7",

language = "English",

volume = "35",

pages = "939--941",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

number = "6",

}

RIS

TY - JOUR

T1 - Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer.

AU - Fitzsimmons, D.

AU - Johnson, C. D.

AU - George, S.

AU - Payne, Sheila

AU - Andrén Sandberg, A.

AU - Bassi, C.

AU - Beger, H. G.

AU - Birk, D.

AU - Büchler, M. W.

AU - Dervenis, C.

AU - Fernandez Cruz, L.

AU - Friess, H.

AU - Grahm, A. L.

AU - Jeekel, J.

AU - Laugier, R.

AU - Meyer, D.

AU - Singer, M. W.

AU - Tihanyi, T.

AU - EORTC Study Group on Quality of Life, The

PY - 1999/6

Y1 - 1999/6

N2 - There is overwhelming consensus that quality of life assessment is urgently required in pancreatic cancer, yet little research has been conducted. We report on the development of a disease specific questionnaire module to supplement the EORTC core cancer module, the QLQ-C30 in patients with pancreatic cancer, using EORTC quality of life study group guidelines for module development. Relevant QoL issues were generated from literature searches and interviews with health professionals and patients with pancreatic cancer. Issues were constructed into items and provisionally translated. The provisional module was pretested in patients in 8 European centres. The resulting module the QLQ-PAN26 includes 26 items related to disease symptoms, treatment side-effects and emotional issues specific to pancreatic cancer. This should ensure that the module will be sensitive to assess the small but important disease and treatment related QoL changes in pancreatic cancer. The use of the QLQ-C30 and QLQ-PAN26 will provide a comprehensive system of QoL assessment in international trials of pancreatic cancer.

AB - There is overwhelming consensus that quality of life assessment is urgently required in pancreatic cancer, yet little research has been conducted. We report on the development of a disease specific questionnaire module to supplement the EORTC core cancer module, the QLQ-C30 in patients with pancreatic cancer, using EORTC quality of life study group guidelines for module development. Relevant QoL issues were generated from literature searches and interviews with health professionals and patients with pancreatic cancer. Issues were constructed into items and provisionally translated. The provisional module was pretested in patients in 8 European centres. The resulting module the QLQ-PAN26 includes 26 items related to disease symptoms, treatment side-effects and emotional issues specific to pancreatic cancer. This should ensure that the module will be sensitive to assess the small but important disease and treatment related QoL changes in pancreatic cancer. The use of the QLQ-C30 and QLQ-PAN26 will provide a comprehensive system of QoL assessment in international trials of pancreatic cancer.

KW - pancreatic neoplasm

KW - quality of life

KW - EORTC QLQ-C30

KW - questionnaire

U2 - 10.1016/S0959-8049(99)00047-7

DO - 10.1016/S0959-8049(99)00047-7

M3 - Journal article

VL - 35

SP - 939

EP - 941

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 6

ER -

Research

Links

Text available via DOI:

Keywords